HK Stock MarketDetailed Quotes

01952 EVEREST MED-B

Watchlist
  • 21.800
  • -1.100-4.80%
Trading Apr 19 14:40 CST
7.07BMarket Cap-7585P/E (TTM)

EVEREST MED-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q3)Mar 31, 2020
(FY)Dec 31, 2019
(Q3)Mar 31, 2019
Turnover
884.46%125.93M
752.01%8.9M
23,588.89%12.79M
--1.04M
--54K
----
----
----
----
----
Operating income
884.46%125.93M
752.01%8.9M
23,588.89%12.79M
1.04M
54K
Cost of sales
-640.88%-34.41M
-811.54%-3.32M
-20,095.65%-4.65M
---364K
---23K
----
----
----
----
----
Operating expenses
-640.88%-34.41M
-811.54%-3.32M
-20,095.65%-4.65M
-364K
-23K
Gross profit
1,023.33%91.52M
720.15%5.58M
26,180.65%8.15M
680K
31K
Selling expenses
29.16%-231.42M
56.72%-64.13M
-64.87%-326.69M
-251.94%-148.16M
-496.01%-198.15M
---42.1M
---33.25M
---2.8M
----
----
Administrative expenses
40.28%-165.16M
30.09%-83.13M
-13.96%-276.55M
-10.69%-118.91M
12.65%-242.68M
---107.43M
-415.93%-277.83M
-740.09%-68.15M
25.31%-53.85M
---8.11M
Research and development expenses
33.30%-540.05M
16.50%-288.49M
-32.00%-809.74M
-37.78%-345.51M
-62.54%-613.43M
---250.77M
-150.13%-377.41M
-251.56%-80.18M
-169.87%-150.89M
---22.81M
Special items of operating profit
-107.63%-87.63M
-75.70%-48.75M
4,015.37%1.15B
-365.43%-27.75M
84,433.33%27.9M
---5.96M
-99.88%33K
-75.40%153K
3,369.94%28.63M
--622K
Operating profit
-263.22%-932.74M
25.13%-478.93M
74.98%-256.8M
-57.45%-639.65M
-49.08%-1.03B
-406.26M
-290.92%-688.46M
-398.31%-150.98M
-38.47%-176.11M
-30.3M
Financing income
157.27%84.61M
1,075.59%54.76M
36.66%32.89M
---5.61M
175.86%24.07M
----
---31.73M
----
----
----
Financing cost
----
----
----
----
----
--26.52M
----
-42.18%-573K
-46.94%-1.95M
---403K
Special items of earning before tax
115.70%3.67M
102.43%554K
-262.09%-23.36M
-576.94%-22.78M
99.87%-6.45M
---3.37M
-13,446.16%-4.94B
250.87%455.51M
95.78%-36.45M
--129.82M
Earning before tax
-241.51%-844.46M
36.59%-423.61M
75.49%-247.28M
-74.37%-668.04M
82.17%-1.01B
-383.11M
-2,537.69%-5.66B
206.65%303.96M
78.37%-214.51M
99.12M
Tax
----
----
---8K
----
----
----
----
----
----
----
After-tax profit from continuing operations
-241.50%-844.46M
36.59%-423.61M
75.49%-247.28M
-74.37%-668.04M
82.17%-1.01B
-383.11M
-2,537.69%-5.66B
206.65%303.96M
78.37%-214.51M
99.12M
Earning after tax
-241.50%-844.46M
36.59%-423.61M
75.49%-247.28M
-74.37%-668.04M
82.17%-1.01B
-383.11M
-2,537.69%-5.66B
206.65%303.96M
78.37%-214.51M
99.12M
Profit attributable to shareholders
-241.50%-844.46M
36.59%-423.61M
75.49%-247.28M
-74.37%-668.04M
82.17%-1.01B
-383.11M
-2,537.69%-5.66B
206.65%303.96M
78.37%-214.51M
99.12M
Basic earnings per share
-225.30%-2.7
38.05%-1.4
75.87%-0.83
-72.52%-2.26
94.81%-3.44
-1.31
-61.53%-66.29
-69.15%12.29
94.35%-41.04
39.84
Diluted earnings per share
-225.30%-2.7
38.05%-1.4
75.87%-0.83
-72.52%-2.26
94.81%-3.44
-1.31
-61.53%-66.29
-223.81%-0.68
94.35%-41.04
-0.21
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q3)Mar 31, 2020(FY)Dec 31, 2019(Q3)Mar 31, 2019
Turnover 884.46%125.93M752.01%8.9M23,588.89%12.79M--1.04M--54K--------------------
Operating income 884.46%125.93M752.01%8.9M23,588.89%12.79M1.04M54K
Cost of sales -640.88%-34.41M-811.54%-3.32M-20,095.65%-4.65M---364K---23K--------------------
Operating expenses -640.88%-34.41M-811.54%-3.32M-20,095.65%-4.65M-364K-23K
Gross profit 1,023.33%91.52M720.15%5.58M26,180.65%8.15M680K31K
Selling expenses 29.16%-231.42M56.72%-64.13M-64.87%-326.69M-251.94%-148.16M-496.01%-198.15M---42.1M---33.25M---2.8M--------
Administrative expenses 40.28%-165.16M30.09%-83.13M-13.96%-276.55M-10.69%-118.91M12.65%-242.68M---107.43M-415.93%-277.83M-740.09%-68.15M25.31%-53.85M---8.11M
Research and development expenses 33.30%-540.05M16.50%-288.49M-32.00%-809.74M-37.78%-345.51M-62.54%-613.43M---250.77M-150.13%-377.41M-251.56%-80.18M-169.87%-150.89M---22.81M
Special items of operating profit -107.63%-87.63M-75.70%-48.75M4,015.37%1.15B-365.43%-27.75M84,433.33%27.9M---5.96M-99.88%33K-75.40%153K3,369.94%28.63M--622K
Operating profit -263.22%-932.74M25.13%-478.93M74.98%-256.8M-57.45%-639.65M-49.08%-1.03B-406.26M-290.92%-688.46M-398.31%-150.98M-38.47%-176.11M-30.3M
Financing income 157.27%84.61M1,075.59%54.76M36.66%32.89M---5.61M175.86%24.07M-------31.73M------------
Financing cost ----------------------26.52M-----42.18%-573K-46.94%-1.95M---403K
Special items of earning before tax 115.70%3.67M102.43%554K-262.09%-23.36M-576.94%-22.78M99.87%-6.45M---3.37M-13,446.16%-4.94B250.87%455.51M95.78%-36.45M--129.82M
Earning before tax -241.51%-844.46M36.59%-423.61M75.49%-247.28M-74.37%-668.04M82.17%-1.01B-383.11M-2,537.69%-5.66B206.65%303.96M78.37%-214.51M99.12M
Tax -----------8K----------------------------
After-tax profit from continuing operations -241.50%-844.46M36.59%-423.61M75.49%-247.28M-74.37%-668.04M82.17%-1.01B-383.11M-2,537.69%-5.66B206.65%303.96M78.37%-214.51M99.12M
Earning after tax -241.50%-844.46M36.59%-423.61M75.49%-247.28M-74.37%-668.04M82.17%-1.01B-383.11M-2,537.69%-5.66B206.65%303.96M78.37%-214.51M99.12M
Profit attributable to shareholders -241.50%-844.46M36.59%-423.61M75.49%-247.28M-74.37%-668.04M82.17%-1.01B-383.11M-2,537.69%-5.66B206.65%303.96M78.37%-214.51M99.12M
Basic earnings per share -225.30%-2.738.05%-1.475.87%-0.83-72.52%-2.2694.81%-3.44-1.31-61.53%-66.29-69.15%12.2994.35%-41.0439.84
Diluted earnings per share -225.30%-2.738.05%-1.475.87%-0.83-72.52%-2.2694.81%-3.44-1.31-61.53%-66.29-223.81%-0.6894.35%-41.04-0.21
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg